AU2002238855A1 - N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same - Google Patents
N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the sameInfo
- Publication number
- AU2002238855A1 AU2002238855A1 AU2002238855A AU2002238855A AU2002238855A1 AU 2002238855 A1 AU2002238855 A1 AU 2002238855A1 AU 2002238855 A AU2002238855 A AU 2002238855A AU 2002238855 A AU2002238855 A AU 2002238855A AU 2002238855 A1 AU2002238855 A1 AU 2002238855A1
- Authority
- AU
- Australia
- Prior art keywords
- compound
- processes
- producing
- active ingredient
- phenylarylsulfonamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title 3
- 239000004480 active ingredient Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drugs Drugs 0.000 title 1
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001068498 | 2001-03-12 | ||
JP2001-68498 | 2001-03-12 | ||
JP2001281569 | 2001-09-17 | ||
JP2001-281569 | 2001-09-17 | ||
JP2002-7760 | 2002-01-16 | ||
JP2002007760 | 2002-01-16 | ||
PCT/JP2002/002245 WO2002072564A1 (en) | 2001-03-12 | 2002-03-11 | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002238855A1 true AU2002238855A1 (en) | 2003-03-20 |
AU2002238855B2 AU2002238855B2 (en) | 2007-12-06 |
Family
ID=27346214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002238855A Ceased AU2002238855B2 (en) | 2001-03-12 | 2002-03-11 | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
Country Status (24)
Country | Link |
---|---|
US (3) | US7235667B2 (en) |
EP (2) | EP1369419B1 (en) |
JP (3) | JP3555620B2 (en) |
KR (1) | KR100886854B1 (en) |
CN (1) | CN1294126C (en) |
AT (2) | ATE522513T1 (en) |
AU (1) | AU2002238855B2 (en) |
BR (1) | BR0208027A (en) |
CA (1) | CA2439604C (en) |
CZ (1) | CZ304035B6 (en) |
DE (1) | DE60220255T2 (en) |
DK (2) | DK1612208T3 (en) |
ES (1) | ES2286230T3 (en) |
HU (1) | HU230056B1 (en) |
IL (2) | IL157701A0 (en) |
MX (1) | MXPA03008134A (en) |
NO (1) | NO329682B1 (en) |
NZ (1) | NZ528120A (en) |
PL (1) | PL218750B1 (en) |
PT (2) | PT1369419E (en) |
RU (1) | RU2299202C2 (en) |
TW (1) | TWI317359B (en) |
WO (1) | WO2002072564A1 (en) |
ZA (1) | ZA200306884B (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003264388A1 (en) * | 2002-09-09 | 2004-03-29 | Ono Pharmaceutical Co., Ltd. | Process for producing 4-methyl-1,3-thiazol-2-ylsulfonyl halide |
PT1603893E (en) * | 2003-01-29 | 2008-08-21 | Asterand Uk Ltd | Ep4 receptor antagonists |
GB0317500D0 (en) * | 2003-07-25 | 2003-08-27 | Pfizer Ltd | Treatment of bph |
EP1642594A1 (en) * | 2003-06-27 | 2006-04-05 | Ono Pharmaceutical Co., Ltd. | Remedy for urinary tract diseases |
GB0401334D0 (en) * | 2004-01-21 | 2004-02-25 | Novartis Ag | Organic compounds |
JPWO2006004115A1 (en) * | 2004-07-05 | 2008-04-24 | 中外製薬株式会社 | Overactive bladder treatment |
JP2008189549A (en) * | 2005-05-12 | 2008-08-21 | Astellas Pharma Inc | Carboxylic acid derivative or its salt |
JP2009057282A (en) * | 2005-12-19 | 2009-03-19 | Astellas Pharma Inc | Carboxylic acid derivative or salt thereof |
TW200817319A (en) | 2006-08-10 | 2008-04-16 | Astellas Pharma Inc | Sulfonamide compound or salt thereof |
CA2677769C (en) * | 2007-02-16 | 2016-01-19 | Ono Pharmaceutical Co., Ltd. | Therapeutic agent for urinary excretion disorder |
SI2177512T1 (en) * | 2007-08-01 | 2012-06-29 | Taisho Pharmaceutical Co Ltd | Inhibitor of binding of s1p1 |
EP2116618A1 (en) * | 2008-05-09 | 2009-11-11 | Agency for Science, Technology And Research | Diagnosis and treatment of Kawasaki disease |
CA2728511A1 (en) * | 2008-06-23 | 2009-12-30 | Astellas Pharma Inc. | Sulfonamide compounds or salts thereof |
TW201107309A (en) * | 2009-07-27 | 2011-03-01 | Kissei Pharmaceutical | Indole derivatives, or the pharmaceutically acceptable salts |
JP2013532688A (en) | 2010-07-26 | 2013-08-19 | ブリストル−マイヤーズ スクイブ カンパニー | Sulfonamide compounds useful as CYP17 inhibitors |
JP5363636B2 (en) * | 2011-10-21 | 2013-12-11 | ファイザー・リミテッド | New salts and medical uses |
US20140039004A1 (en) * | 2012-07-31 | 2014-02-06 | Ono Pharmaceutical Co., Ltd. | Method of treating of gastroesophageal reflux disease |
JP6103893B2 (en) * | 2012-11-15 | 2017-03-29 | サントリー食品インターナショナル株式会社 | Coffee oil production method |
EP3138633B1 (en) * | 2014-04-30 | 2018-11-21 | Industrias Peñalver, S.L. | Programmable concentric head for the application of liquid to lids of different shapes |
US10227338B2 (en) * | 2015-11-13 | 2019-03-12 | Daewoong Pharmaceutical Co., Ltd. | Substituted benzenesulfonamides as sodium channel blockers |
RU2659955C1 (en) * | 2017-10-26 | 2018-07-04 | Галина Ильхамовна Лукина | Method for diagnosing high gastroesophageal refluxes |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2419923A1 (en) * | 1973-04-28 | 1974-11-28 | Fujisawa Pharmaceutical Co | SULPHONIC ACID ESTERS, PROCESS FOR THEIR PRODUCTION AND USE AS A CONDENSATION AGENT |
JPS5748534B2 (en) | 1974-03-04 | 1982-10-16 | ||
DE2555048A1 (en) * | 1975-12-06 | 1977-06-30 | Pfersee Chem Fab | PROCESS AND DEVICE FOR THE PRODUCTION OF PERMANENT, Aqueous EMULSIONS OF WATER-INSOLUBLE SUBSTANCES |
JPS5293469A (en) * | 1976-02-02 | 1977-08-05 | Fuji Photo Film Co Ltd | Method of curing gelatin |
JPH05293469A (en) | 1992-04-17 | 1993-11-09 | Toda Constr Co Ltd | Production of sterilized and purified water and equipment thereof |
TW523506B (en) * | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
AU4431400A (en) * | 1999-05-12 | 2000-12-05 | Japan As Represented By President Of National Cancer Center | Anticancer agents containing ep1 antagonists as the active ingredient |
WO2001008674A1 (en) | 1999-07-29 | 2001-02-08 | Ono Pharmaceutical Co., Ltd. | Sulfonamide derivatives and remedies for allodynia |
EP1369129A4 (en) * | 2001-03-14 | 2005-08-03 | Ono Pharmaceutical Co | Remedies for depression containing ep1 antagonist as the active ingredient |
-
2002
- 2002-03-11 WO PCT/JP2002/002245 patent/WO2002072564A1/en active IP Right Grant
- 2002-03-11 DK DK05109059.5T patent/DK1612208T3/en active
- 2002-03-11 AU AU2002238855A patent/AU2002238855B2/en not_active Ceased
- 2002-03-11 EP EP02705096A patent/EP1369419B1/en not_active Expired - Lifetime
- 2002-03-11 JP JP2002571480A patent/JP3555620B2/en not_active Expired - Fee Related
- 2002-03-11 DE DE60220255T patent/DE60220255T2/en not_active Expired - Lifetime
- 2002-03-11 DK DK02705096T patent/DK1369419T3/en active
- 2002-03-11 AT AT05109059T patent/ATE522513T1/en active
- 2002-03-11 AT AT02705096T patent/ATE362924T1/en active
- 2002-03-11 US US10/471,673 patent/US7235667B2/en not_active Expired - Fee Related
- 2002-03-11 BR BR0208027-3A patent/BR0208027A/en not_active IP Right Cessation
- 2002-03-11 PT PT02705096T patent/PT1369419E/en unknown
- 2002-03-11 RU RU2003127677/04A patent/RU2299202C2/en not_active IP Right Cessation
- 2002-03-11 EP EP05109059A patent/EP1612208B1/en not_active Expired - Lifetime
- 2002-03-11 TW TW091104451A patent/TWI317359B/en not_active IP Right Cessation
- 2002-03-11 IL IL15770102A patent/IL157701A0/en unknown
- 2002-03-11 PT PT05109059T patent/PT1612208E/en unknown
- 2002-03-11 CN CNB028097904A patent/CN1294126C/en not_active Expired - Fee Related
- 2002-03-11 KR KR1020037011921A patent/KR100886854B1/en not_active IP Right Cessation
- 2002-03-11 CZ CZ20032452A patent/CZ304035B6/en not_active IP Right Cessation
- 2002-03-11 ES ES02705096T patent/ES2286230T3/en not_active Expired - Lifetime
- 2002-03-11 PL PL365100A patent/PL218750B1/en unknown
- 2002-03-11 NZ NZ528120A patent/NZ528120A/en not_active IP Right Cessation
- 2002-03-11 HU HU0400155A patent/HU230056B1/en not_active IP Right Cessation
- 2002-03-11 MX MXPA03008134A patent/MXPA03008134A/en active IP Right Grant
- 2002-03-11 CA CA2439604A patent/CA2439604C/en not_active Expired - Fee Related
-
2003
- 2003-09-02 IL IL157701A patent/IL157701A/en not_active IP Right Cessation
- 2003-09-03 ZA ZA2003/06884A patent/ZA200306884B/en unknown
- 2003-09-10 NO NO20034007A patent/NO329682B1/en not_active IP Right Cessation
- 2003-12-24 JP JP2003427226A patent/JP3741120B2/en not_active Expired - Fee Related
-
2005
- 2005-08-26 JP JP2005245763A patent/JP4432051B2/en not_active Expired - Fee Related
- 2005-09-30 US US11/239,406 patent/US7629369B2/en not_active Expired - Fee Related
-
2009
- 2009-10-21 US US12/603,194 patent/US8088802B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002238855A1 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
AU2002337047A1 (en) | Novel dihydropteridinones, method for producing the same and the use thereof as medicaments | |
HUP0400155A3 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
HUP0204170A3 (en) | 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient | |
TWI328576B (en) | Diketohydrazine derivative compound, medicament containing same as active ingredient | |
AU2002238947A1 (en) | Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient | |
AU2002354054A1 (en) | Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient | |
AU2001241056A1 (en) | Spiro compounds, process for preparing the same and use thereof as drugs | |
AU2002309038A1 (en) | Compositions for transmucosal administration containing coenzyme Q as the active ingredient | |
AU2001234107A1 (en) | Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient | |
MXPA03006648A (en) | Anti-thrombotic compounds, production and use thereof as medicaments. | |
AU2002325614A1 (en) | Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances | |
AU2001241067A1 (en) | Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient | |
AU2002363776A1 (en) | Carboxylic acid derivative compounds and drugs containing the same as the active ingredient | |
EP1199076A3 (en) | Medicament containing tocotrienol as active component | |
AU2003284769A1 (en) | 1,2,4-triazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
AU2002343729A1 (en) | Compound prioritization for drug discovery | |
AU2003284759A1 (en) | Thione derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
AU2002335354A1 (en) | Indole derivatives, process for producing the same and drugs containing the same as the active ingredient | |
AU2002308369A1 (en) | 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof | |
AU2002232239A1 (en) | Pyrazole derivative, intermediate therefor, processes for producing these, and herbicide containing these as active ingredient | |
AU2002244962A1 (en) | Pyrazolecarboxamide derivative, intermediate therefor, and pest control agent containing the same as active ingredient | |
MXPA03008636A (en) | Isoquinuclidine derivative, process for producing the same, and medicinal composition containing the same. | |
AU2002355890A1 (en) | Active ingredient mixtures | |
AU2002361987A1 (en) | Substituted beta-aminoalcohols used as medicaments |